Clinical trials
Coronary Stenosis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2008 | 3 |
| 2009 | 5 |
| 2010 | 8 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 5 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 41 |
| Terminated | 6 |
| Recruiting | 3 |
| Active, not recruiting | 3 |
| Not yet recruiting | 2 |
| Unknown status | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbott Medical Devices | 18 |
| Angiowave Imaging | 2 |
| Bracco Diagnostics, Inc | 2 |
| Medinol Ltd. | 2 |
| Volcano Corporation | 2 |
| Anesiva, Inc. | 1 |
| Boston Scientific Corporation | 1 |
| CAMC Health System | 1 |
| Central Arkansas Veterans Healthcare System | 1 |
| Columbia University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Stenosis | 58 |
| Coronary Artery Disease | 36 |
| Myocardial Ischemia | 20 |
| Coronary Disease | 17 |
| Coronary Restenosis | 15 |
| Vascular Diseases | 9 |
| Angina Pectoris | 4 |
| Coronary Occlusion | 4 |
| Myocardial Infarction | 4 |
| Chest Pain | 3 |
Trials
Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.